3351 - 3400 of 6258 Results
Title
Year
- Enhanced Parkinson’s Disease Tremor Severity Classification by Combining Signal Processing with Resampling Techniques2021OPENTitle: Enhanced Parkinson’s Disease Tremor Severity Classification by Combining Signal Processing with Resampling TechniquesJournal Name: SN Computer SciencePublisher: Springer Science and Business Media LLCVol: 3Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s42979-021-00953-6Best OA location URL: https://link.springer.com/content/pdf/10.1007/s42979-021-00953-6.pdfCitation Count: 18
- Subthalamic nucleus—sensorimotor cortex functional connectivity in de novo and moderate Parkinson's disease2014OPENTitle: Subthalamic nucleus—sensorimotor cortex functional connectivity in de novo and moderate Parkinson's diseaseJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 36Issue #: 1Start Page: 462End Page: 469Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2014.07.004Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/4268125Citation Count: 47
-
OPENTitle: Effect of augmenting cholinergic function on gait and balanceJournal Name: BMC NeurologyPublisher: Springer Science and Business Media LLCVol: 15Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12883-015-0523-xBest OA location URL: https://bmcneurol.biomedcentral.com/track/pdf/10.1186/s12883-015-0523-xCitation Count: 25
- Anatomical substrates and connectivity for bradykinesia motor features in Parkinson’s disease after subthalamic nucleus deep brain stimulation2023OPENTitle: Anatomical substrates and connectivity for bradykinesia motor features in Parkinson’s disease after subthalamic nucleus deep brain stimulationJournal Name: Brain CommunicationsPublisher: Oxford University Press (OUP)Vol: 5Issue #: 6Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/braincomms/fcad337Best OA location URL: https://academic.oup.com/braincomms/advance-article-pdf/doi/10.1093/braincomms/fcad337/54424551/fcad337.pdfCitation Count: 1
-
OPENTitle: Postmortem Interval Influencesα-Synuclein Expression in Parkinson Disease BrainJournal Name: Parkinson's DiseasePublisher: WileyVol: 2012Issue #:Start Page: 1End Page: 8Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2012/614212Best OA location URL: https://downloads.hindawi.com/journals/pd/2012/614212.pdfCitation Count: 12
- The spatial landscape of glial pathology and T cell response in Parkinson’s disease substantia nigra2025OPENTitle: The spatial landscape of glial pathology and T cell response in Parkinson’s disease substantia nigraJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 16Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/s41467-025-62478-3Best OA location URL: https://www.nature.com/articles/s41467-025-62478-3.pdfCitation Count: 0
- MAPT allele and haplotype frequencies in Nigerian Africans: Population distribution and association with Parkinson's disease risk and age at onset2023OPENTitle: MAPT allele and haplotype frequencies in Nigerian Africans: Population distribution and association with Parkinson's disease risk and age at onsetJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 113Issue #:Start Page: 105517End Page: 105517Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2023.105517Best OA location URL: https://discovery.ucl.ac.uk/10177992/3/Hardy_MAPT%20allele%20and%20haplotype%20frequencies%20in%20Nigerian%20Africans_AAM.pdfCitation Count: 3
- Development and validation of a sensitive HPLC-HESI-MS/MS method for quantitative determination of bitopertin in rat and marmoset plasma2020OPENTitle: Development and validation of a sensitive HPLC-HESI-MS/MS method for quantitative determination of bitopertin in rat and marmoset plasmaJournal Name: MNI Open ResearchPublisher: F1000 Research LtdVol: 4Issue #:Start Page: 2End Page: 2Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.12688/mniopenres.12850.1Best OA location URL: https://mniopenresearch.org/articles/4-2/v1/pdfCitation Count: 2
-
OPENTitle: Optical Structural Analysis of Individual α‐Synuclein OligomersJournal Name: Angewandte ChemiePublisher: WileyVol: 130Issue #: 18Start Page: 4980End Page: 4984Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1002/ange.201710779Best OA location URL: https://doi.org/10.1002/ange.201710779Citation Count: 0
- Dissociation between urate and blood pressure in mice and in people with early Parkinson's disease2018OPENTitle: Dissociation between urate and blood pressure in mice and in people with early Parkinson's diseaseJournal Name: EBioMedicinePublisher: Elsevier BVVol: 37Issue #:Start Page: 259End Page: 268Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.ebiom.2018.10.039Best OA location URL: http://www.thelancet.com/article/S2352396418304572/pdfCitation Count: 9
- The Michael J. Fox Foundation’s Strategies for Accelerating Translation of LRRK2 into Therapies for Parkinson Disease2020OPENTitle: The Michael J. Fox Foundation’s Strategies for Accelerating Translation of LRRK2 into Therapies for Parkinson DiseaseJournal Name: CellsPublisher: MDPI AGVol: 9Issue #: 8Start Page: 1878End Page: 1878Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/cells9081878Best OA location URL: https://www.mdpi.com/2073-4409/9/8/1878/pdf?version=1597644425Citation Count: 6
- Determination of optimal vibration dose to treat Parkinson's disease gait symptoms: A clinical trial2024OPENTitle: Determination of optimal vibration dose to treat Parkinson's disease gait symptoms: A clinical trialJournal Name: Clinical Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 10Issue #:Start Page: 100248End Page: 100248Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.prdoa.2024.100248Best OA location URL: https://doi.org/10.1016/j.prdoa.2024.100248Citation Count: 0
- Analysis of modular gene co-expression networks reveals molecular pathways underlying Alzheimer’s disease and progressive supranuclear palsy2022OPENTitle: Analysis of modular gene co-expression networks reveals molecular pathways underlying Alzheimer’s disease and progressive supranuclear palsyJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 17Issue #: 4Start Page: e0266405End Page: e0266405Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0266405Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0266405&type=printableCitation Count: 5
- Mechanisms of Alpha-Synuclein-Seeded Aggregation in Neurons Revealed by Fluorescence Lifetime Imaging2025OPENTitle: Mechanisms of Alpha-Synuclein-Seeded Aggregation in Neurons Revealed by Fluorescence Lifetime ImagingJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 16Issue #: 11Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1021/acschemneuro.5c00236Best OA location URL: https://doi.org/10.1021/acschemneuro.5c00236Citation Count: 0
- Application of new biologic disease criteria for synucleinopathies to the systemic synuclein sampling study cohort2025OPENTitle: Application of new biologic disease criteria for synucleinopathies to the systemic synuclein sampling study cohortJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-025-00919-yBest OA location URL: https://resolver.sub.uni-goettingen.de/purl?gro-2/148945Citation Count: 0
-
OPENTitle: Activation of parkin by a molecular glueJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 15Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/s41467-024-51889-3Best OA location URL: https://doi.org/10.1038/s41467-024-51889-3Citation Count: 9
-
OPENTitle: A predictive algorithm to identify ever smoking in medical claims-based epidemiologic studiesJournal Name: Annals of EpidemiologyPublisher: Elsevier BVVol: 85Issue #:Start Page: 59End Page: 67.e6Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.annepidem.2023.04.019Best OA location URL: https://doi.org/10.1016/j.annepidem.2023.04.019Citation Count: 3
- Interview with Mark Frasier: A Michael J Fox Foundation Perspective on Precision Medicine in Parkinson’S2016OPENTitle: Interview with Mark Frasier: A Michael J Fox Foundation Perspective on Precision Medicine in Parkinson’SJournal Name: Personalized MedicinePublisher: Informa UK LimitedVol: 14Issue #: 1Start Page: 13End Page: 15Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.2217/pme-2016-0087Best OA location URL: https://www.futuremedicine.com/doi/pdf/10.2217/pme-2016-0087Citation Count: 0
- Development of a simplified smell test to identify Parkinson’s disease using multiple cohorts, machine learning and item response theory2025OPENTitle: Development of a simplified smell test to identify Parkinson’s disease using multiple cohorts, machine learning and item response theoryJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-025-00904-5Best OA location URL: https://resolver.sub.uni-goettingen.de/purl?gro-2/148944Citation Count: 1
- A clinical, molecular genetics and pathological study of a FTDP-17 family with a heterozygous splicing variant c.823-10G>T at the intron 9/exon 10 of the MAPT gene2021OPENTitle: A clinical, molecular genetics and pathological study of a FTDP-17 family with a heterozygous splicing variant c.823-10G>T at the intron 9/exon 10 of the MAPT geneJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 106Issue #:Start Page: 343.e1End Page: 343.e8Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2021.05.010Best OA location URL: https://doi.org/10.1016/j.neurobiolaging.2021.05.010Citation Count: 6
-
OPENTitle: Pregnenolone Reduces L‐Dopa‐Induced Dyskinesias in Female Parkinsonian MonkeysJournal Name: Movement DisordersPublisher: WileyVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.30280Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.30280Citation Count: 0
- Elevated In Vitro Kinase Activity in Peripheral Blood Mononuclear Cells of Leucine‐Rich Repeat Kinase 2 G2019S Carriers: A Novel Enzyme‐Linked Immunosorbent Assay–Based Method2020OPENTitle: Elevated In Vitro Kinase Activity in Peripheral Blood Mononuclear Cells of Leucine‐Rich Repeat Kinase 2 G2019S Carriers: A Novel Enzyme‐Linked Immunosorbent Assay–Based MethodJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 11Start Page: 2095End Page: 2100Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28175Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28175Citation Count: 29
-
OPENTitle: Movement disorders in non-encephalopathic Hashimoto's thyroiditisJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 55Issue #:Start Page: 141End Page: 142Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.06.008Best OA location URL: https://zenodo.org/record/3873759Citation Count: 17
-
OPENTitle: No diurnal variation of classical and candidate biomarkers of Alzheimer’s disease in CSFJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13024-016-0130-3Best OA location URL: https://molecularneurodegeneration.biomedcentral.com/track/pdf/10.1186/s13024-016-0130-3Citation Count: 21
-
OPENTitle: Neurofilament Light Chain as a Biomarker for Cognitive Decline in Parkinson DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 12Start Page: 2945End Page: 2950Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28779Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8688198Citation Count: 135
- Common Variants Coregulate Expression of GBA and Modifier Genes to Delay Parkinson's Disease Onset2020OPENTitle: Common Variants Coregulate Expression of GBA and Modifier Genes to Delay Parkinson's Disease OnsetJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 8Start Page: 1346End Page: 1356Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28144Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28144Citation Count: 30
-
OPENTitle: Chronotype, sleep, and sleepiness in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 106Issue #:Start Page: 105189End Page: 105189Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.10.011Best OA location URL: https://doi.org/10.1016/j.parkreldis.2022.10.011Citation Count: 8
-
OPENTitle: RGS10 attenuates systemic immune dysregulation induced by chronic inflammatory stressJournal Name: Journal of NeuroinflammationPublisher: Springer Science and Business Media LLCVol: 22Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12974-024-03322-1Best OA location URL: https://doi.org/10.1186/s12974-024-03322-1Citation Count: 0
- Generation of two human induced pluripotent stem cell lines from fibroblasts of unrelated Parkinson’s patients carrying the G2019S mutation in the LRRK2 gene (LCSBi005, LCSBi006)2021OPENTitle: Generation of two human induced pluripotent stem cell lines from fibroblasts of unrelated Parkinson’s patients carrying the G2019S mutation in the LRRK2 gene (LCSBi005, LCSBi006)Journal Name: Stem Cell ResearchPublisher: Elsevier BVVol: 57Issue #:Start Page: 102569End Page: 102569Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.scr.2021.102569Best OA location URL: https://doi.org/10.1016/j.scr.2021.102569Citation Count: 2
- Key Connectomes and Synaptic‐Compartment‐Specific Risk Genes Drive Pathological α‐Synuclein Spreading2025OPENTitle: Key Connectomes and Synaptic‐Compartment‐Specific Risk Genes Drive Pathological α‐Synuclein SpreadingJournal Name: Advanced SciencePublisher: WileyVol: 12Issue #: 25Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/advs.202413052Best OA location URL: https://advanced.onlinelibrary.wiley.com/doi/pdf/10.1002/advs.202413052Citation Count: 1
-
OPENTitle: New aspects of USP30 biology in the regulation of pexophagyJournal Name: AutophagyPublisher: Informa UK LimitedVol: 15Issue #: 9Start Page: 1634End Page: 1637Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1080/15548627.2019.1615304Best OA location URL: https://www.tandfonline.com/doi/pdf/10.1080/15548627.2019.1615304?needAccess=trueCitation Count: 14
- Activation of FADD-Dependent Neuronal Death Pathways as a Predictor of Pathogenicity for LRRK2 Mutations2016OPENTitle: Activation of FADD-Dependent Neuronal Death Pathways as a Predictor of Pathogenicity for LRRK2 MutationsJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 11Issue #: 11Start Page: e0166053End Page: e0166053Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0166053Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0166053&type=printableCitation Count: 18
- Beta2-adrenoreceptor agonist clenbuterol produces transient decreases in alpha-synuclein mRNA but no long-term reduction in protein2022OPENTitle: Beta2-adrenoreceptor agonist clenbuterol produces transient decreases in alpha-synuclein mRNA but no long-term reduction in proteinJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00322-xBest OA location URL: https://www.nature.com/articles/s41531-022-00322-x.pdfCitation Count: 9
-
OPENTitle: Transglutaminase 2 Depletion Attenuates α-Synuclein Mediated Toxicity in MiceJournal Name: NeurosciencePublisher: Elsevier BVVol: 441Issue #:Start Page: 58End Page: 64Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.neuroscience.2020.05.047Best OA location URL: https://doi.org/10.1016/j.neuroscience.2020.05.047Citation Count: 18
- Alpha1-chimaerin, a Rac1 GTPase-activating protein, is expressed at reduced mRNA levels in the brain of Alzheimer’s disease patients2015OPENTitle: Alpha1-chimaerin, a Rac1 GTPase-activating protein, is expressed at reduced mRNA levels in the brain of Alzheimer’s disease patientsJournal Name: Neuroscience LettersPublisher: Elsevier BVVol: 591Issue #:Start Page: 19End Page: 24Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neulet.2015.02.013Best OA location URL: http://doi.org/10.1016/j.neulet.2015.02.013Citation Count: 11
-
OPENTitle: Increased substantia nigra echogenicity in LRRK2 family members without mutationsJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 9Start Page: 1504End Page: 1505Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.27443Best OA location URL: https://europepmc.org/articles/pmc6346431?pdf=renderCitation Count: 2
- Reverters from PD-MCI to cognitively intact are at risk for future cognitive impairment: Analysis of the PPMI cohort2017OPENTitle: Reverters from PD-MCI to cognitively intact are at risk for future cognitive impairment: Analysis of the PPMI cohortJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 47Issue #:Start Page: 3End Page: 7Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2017.12.006Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5803409Citation Count: 47
-
OPENTitle: Post‐traumatic Functional Mirror Movements in Klippel‐Feil SyndromeJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 4Issue #: 3Start Page: 447End Page: 449Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12405Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12405Citation Count: 1
-
OPENTitle: A randomized, double‐blind, placebo‐controlled trial of camicinal in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 2Start Page: 329End Page: 332Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.27259Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.27259Citation Count: 16
-
OPENTitle: Parkinson’s Disease Recognition Using SPECT Image and Interpretable AI: A TutorialJournal Name: IEEE Sensors JournalPublisher: Institute of Electrical and Electronics Engineers (IEEE)Vol: 21Issue #: 20Start Page: 22304End Page: 22316Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1109/jsen.2021.3077949Best OA location URL: https://arxiv.org/pdf/1908.11199Citation Count: 29
- Nanomicellar formulation of coenzyme Q10 (Ubisol-Q10) effectively blocks ongoing neurodegeneration in the mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model: potential use as an adjuvant treatment in Parkinson's disease2014OPENTitle: Nanomicellar formulation of coenzyme Q10 (Ubisol-Q10) effectively blocks ongoing neurodegeneration in the mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model: potential use as an adjuvant treatment in Parkinson's diseaseJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 35Issue #: 10Start Page: 2329End Page: 2346Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2014.03.032Best OA location URL: http://doi.org/10.1016/j.neurobiolaging.2014.03.032Citation Count: 68
-
OPENTitle: Association of Specific Leg Muscle Strength and Motor Features in Parkinson’s DiseaseJournal Name: Parkinson's DiseasePublisher: WileyVol: 2024Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2024/5580870Best OA location URL: https://doi.org/10.1155/2024/5580870Citation Count: 0
-
OPENTitle: SRF transcriptionally regulates the oligodendrocyte cytoskeleton during CNS myelinationJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 121Issue #: 12Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1073/pnas.2307250121Best OA location URL: https://escholarship.org/content/qt2zh8f5zf/qt2zh8f5zf.pdfCitation Count: 4
-
OPENTitle: Clinical severity in Parkinson’s disease is determined by decline in cortical compensationJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 147Issue #: 3Start Page: 871End Page: 886Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/brain/awad325Best OA location URL: https://academic.oup.com/brain/advance-article-pdf/doi/10.1093/brain/awad325/51777747/awad325.pdfCitation Count: 27
- Targeting PERK signaling with the small molecule GSK2606414 prevents neurodegeneration in a model of Parkinson's disease2018OPENTitle: Targeting PERK signaling with the small molecule GSK2606414 prevents neurodegeneration in a model of Parkinson's diseaseJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 112Issue #:Start Page: 136End Page: 148Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.nbd.2018.01.004Best OA location URL: https://repositorio.uchile.cl/handle/2250/167345Citation Count: 145
-
OPENTitle: Decreased Water Mobility Contributes To Increased α‐Synuclein Aggregation**Journal Name: Angewandte Chemie International EditionPublisher: WileyVol: 62Issue #: 7Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1002/anie.202212063Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/anie.202212063Citation Count: 16
-
OPENTitle: Alpha‐synuclein RT‐QuIC in the CSF of patients with alpha‐synucleinopathiesJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 3Issue #: 10Start Page: 812End Page: 818Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/acn3.338Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acn3.338Citation Count: 479
- Evidence for early and progressive ultrasonic vocalization and oromotor deficits in a PINK1 gene knockout rat model of Parkinson's disease2015OPENTitle: Evidence for early and progressive ultrasonic vocalization and oromotor deficits in a PINK1 gene knockout rat model of Parkinson's diseaseJournal Name: Journal of Neuroscience ResearchPublisher: WileyVol: 93Issue #: 11Start Page: 1713End Page: 1727Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/jnr.23625Citation Count: 95
-
OPENTitle: Using a stable protein scaffold to display peptides that bind to alpha‐synuclein fibrilsJournal Name: Protein SciencePublisher: WileyVol: 34Issue #: 6Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/pro.70150Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/pro.70150Citation Count: 0
- MMP-9 expression is increased in B lymphocytes during multiple sclerosis exacerbation and is regulated by microRNA-320a2014OPENTitle: MMP-9 expression is increased in B lymphocytes during multiple sclerosis exacerbation and is regulated by microRNA-320aJournal Name: Journal of NeuroimmunologyPublisher: Elsevier BVVol: 278Issue #:Start Page: 185End Page: 189Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jneuroim.2014.11.004Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/4297694Citation Count: 64